Expanded Access Policy

We are committed to developing high quality and affordable gene therapies as quickly as possible. Currently, Access to our investigational medicines is only through participation in clinical trials. Frontera is not able to offer expanded access to its investigational medicines. 

Find information on currently enrolling clinical trials for Frontera’s investigational therapies on clinicaltrials.gov.

Frontera reserves the right to revise this policy at any time, in accordance with the 21st Century Cures Act.